New Clinical Trials Tech Company Nimblify, Inc. to Launch Participant Payment System This Fall

Share Article

Clinical trials technology company, Nimblify, Inc., announced its first offering that will be ready this fall, an electronic payment system for clinical research sites and sponsors to compensate study participants.

Nimblify, Inc. logo

Nimblify, Inc., a clinical trials technology startup, announced its first offering that will be made available to research sites and sponsors this fall. The company was formed just last month, spun out of Forte Research Systems, Inc., a clinical research software provider that has been serving the industry for more than 15 years. Today Nimblify announced its next step – the first of several offerings to come – a participant-centered payment technology. This solution will allow research sites and sponsors to immediately pay and reimburse study volunteers after each visit occurs via each participant’s choice of reloadable debit card or direct deposit.

The Need to Improve the Experience for Both Study Participants and Site Staff

The payment of clinical trial participants is rarely hassle-free for both site staff and study volunteers. Check processing can delay payments to study participants by one to two months while other existing solutions tend to be more focused on sponsors’ needs, failing to understand and accommodate site operations. “Now, more than ever, the industry is recognizing the need to be participant-centric, and research institutions need to find better ways to manage financials and improve cash flow,” said Srini Kalluri, Founder & CEO. “We want to make the payment and reimbursement process much simpler for the study coordinators and finance departments that prepare and process payments, while placing the participant at the center,” added Kalluri.

Nimblify Payments is built with research site processes in mind. Kalluri, also the founder of Forte Research Systems, and the Nimblify team are thoroughly familiar with site operations and draw from Forte’s experience of working collaboratively with research sites of all sizes. The new payment technology includes easy workflows for coordinators and a review queue for financial teams to manage and pay reimbursements while staying organized and in control. Having checks and balances in place provides maximum visibility into funds and ensures research volunteers get paid for the correct amount. It also makes it possible to pay them much quicker and in a way that’s preferable to them. “There is room for an innovative solution that starts to involve the participant as an equal and a decision maker, and treating them as such is an important part of the success of the trial,” said Kalluri.

Participant Payments will launch for research sites, CROs and sponsors based in the US and Canada this fall. Nimblify is already working with early collaborators on this offering. To participate in the early adopters program, contact Info(at)Nimblify(dot)com. To be notified when Participant Payments launches, join the pre-launch waiting list here:

About Nimblify, Inc.
Nimblify, Inc., a wholly owned subsidiary of Forte Research Systems, is a clinical trials technology company dedicated to creating industry-wide efficiencies by connecting stakeholders in clinical research. The company’s first offering is a participant-centered payment system that enables research sites and sponsors to easily and securely compensate study volunteers immediately after each visit occurs. Founded in August 2015, Nimblify is a privately held company and is headquartered in Madison, Wis. For more information, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kristina Lopienski
since: 05/2015
Follow >
Nimblify, Inc.
Like >
Nimblify, Inc.

Visit website